Mount Sinai Hospital CEO Dr. Kenneth Davis reportedly sees no antitrust bumps on his organization's path to absorbing Continuum Health Partners into what would be New York City's largest healthcare provider.
The Mount Sinai and Continuum boards just this week signed a definitive agreement. Davis, as paraphrased in the New York Times, said a regional office of the Federal Trade Commission had already given them the all-clear.
The size of the proposed transaction, though, requires a formal application for antitrust review under the Hart-Scott-Rodino Act. The FTC has been keenly interested in hospital deals in the past few years. And the agency has been quite successful lately at scuttling ones it views as likely to lead to higher prices for patients, employers and insurers.